Greywolf Capital Management LP Trimmed Holding in Wmih (WMIH) by $2.38 Million as Shares Rose; As Amgen (AMGN) Share Value Declined, Nuwave Investment Management Has Decreased Position by $438,770

August 12, 2018 - By Vernon Prom

Amgen Inc. (NASDAQ:AMGN) Logo

Nuwave Investment Management Llc decreased its stake in Amgen Inc (AMGN) by 50.8% based on its latest 2018Q1 regulatory filing with the SEC. Nuwave Investment Management Llc sold 2,581 shares as the company’s stock declined 5.44% with the market. The hedge fund held 2,500 shares of the biological products (no diagnostic substances) company at the end of 2018Q1, valued at $427,000, down from 5,081 at the end of the previous reported quarter. Nuwave Investment Management Llc who had been investing in Amgen Inc for a number of months, seems to be less bullish one the $125.84B market cap company. The stock increased 0.23% or $0.45 during the last trading session, reaching $194.42. About 1.52M shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 14.68% since August 12, 2017 and is uptrending. It has outperformed by 2.11% the S&P500. Some Historical AMGN News: 24/04/2018 – AMGEN INC – 2018 TOTAL REVENUE OUTLOOK REVISED TO $21.9 BLN TO $22.8 BLN; 26/04/2018 – Amgen Bond Trading 35x Average; Clients Net Sellers; 03/04/2018 – European Commission Approves Expanded lndication For Amgen’s XGEVA® (denosumab) For The Prevention Of Skeletal-Related Events In Patients With Multiple Myeloma; 18/05/2018 – AMGEN INC AMGN.O : LEERINK RAISES TARGET PRICE TO $210 FROM $206; 30/04/2018 – Fidelity OTC Adds Tencent, Exits Celgene, Cuts Amgen; 22/05/2018 – AMGEN INC – ALL OF DIRECTOR NOMINEES WERE RE-ELECTED TO BOARD AT ANNUAL MEETING OF STOCKHOLDERS; 27/04/2018 – Amgen’s Prolia Gets Use Extension Recommendation in Europe; 17/05/2018 – Novartis and Amgen Announce FDA Approval of Aimovig for Migraine Prevention; 02/04/2018 – STAT Plus: Amgen’s money-back guarantee for its pricey cholesterol drug may not deliver; 29/05/2018 – COHERUS BIOSCIENCES SUBMITTED DAY 181 RESPONSES ON NEULASTA

Greywolf Capital Management Lp decreased its stake in Wmih Corp (WMIH) by 22.42% based on its latest 2018Q1 regulatory filing with the SEC. Greywolf Capital Management Lp sold 2.38M shares as the company’s stock rose 6.20% while stock markets declined. The hedge fund held 8.22 million shares of the company at the end of 2018Q1, valued at $11.68 million, down from 10.60 million at the end of the previous reported quarter. Greywolf Capital Management Lp who had been investing in Wmih Corp for a number of months, seems to be less bullish one the $530.60 million market cap company. The stock increased 1.45% or $0.02 during the last trading session, reaching $1.4. About 2.13 million shares traded. WMIH Corp. (NASDAQ:WMIH) has risen 14.17% since August 12, 2017 and is uptrending. It has outperformed by 1.60% the S&P500. Some Historical WMIH News: 16/04/2018 – S&PGR: Revised Outlook Primarily Reflects Nationstar’s Increasing Leverage Related to Its Merger Agreement With WMIH Corp; 04/05/2018 – MOODY’S: MORTGAGE FINANCE COMPANIES WILL CONTINUE CONSOLIDATING AS PROFITABILITY IS UNDER PRESSURE; 09/03/2018 WMIH Forms Golden Cross: Technicals; 14/05/2018 – Rubric Capital Buys New 2.1% Position in WMIH; 15/05/2018 – Carlson Capital Buys New 1.9% Position in WMIH; 22/04/2018 – DJ WMIH Corp, Inst Holders, 1Q 2018 (WMIH)

Greywolf Capital Management Lp, which manages about $3.21 billion and $153.64 million US Long portfolio, upped its stake in Stars Group Inc by 20,000 shares to 305,000 shares, valued at $8.40 million in 2018Q1, according to the filing.

Since February 14, 2018, it had 0 insider purchases, and 5 sales for $1.36 million activity.

Nuwave Investment Management Llc, which manages about $246.42M and $63.45M US Long portfolio, upped its stake in Crown Castle Intl Corp (NYSE:CCI) by 3,884 shares to 4,278 shares, valued at $469,000 in 2018Q1, according to the filing. It also increased its holding in Lockheed Martin Corp (NYSE:LMT) by 897 shares in the quarter, for a total of 1,068 shares, and has risen its stake in Phillips 66 (NYSE:PSX).

More important recent Amgen Inc. (NASDAQ:AMGN) news were published by: Seekingalpha.com which released: “BeiGene launches late-stage study of tislelizumab in first-line lung cancer” on August 09, 2018, also 247Wallst.com published article titled: “Why Have Short Sellers Backed Off Major Biotechs?”, Fool.com published: “Better Buy: Gilead Sciences, Inc. vs. Amgen Inc.” on August 08, 2018. More interesting news about Amgen Inc. (NASDAQ:AMGN) was released by: Benzinga.com and their article: “Nasdaq, Tech Names Might Come Under Pressure Following Facebook’s Weak Results” with publication date: July 26, 2018.

Investors sentiment decreased to 0.88 in 2018 Q1. Its down 0.34, from 1.22 in 2017Q4. It dropped, as 67 investors sold AMGN shares while 557 reduced holdings. 114 funds opened positions while 435 raised stakes. 502.72 million shares or 8.88% less from 551.71 million shares in 2017Q4 were reported. 606,257 are held by Public Employees Retirement Association Of Colorado. Merriman Wealth Mgmt Limited Com invested 5.97% in Amgen Inc. (NASDAQ:AMGN). Fukoku Mutual Life Insur invested 0.09% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Lenox Wealth has invested 0.01% in Amgen Inc. (NASDAQ:AMGN). Raymond James Advsr Inc accumulated 219,004 shares. Moreover, Piedmont Inv Advsr Ltd Company has 0.6% invested in Amgen Inc. (NASDAQ:AMGN). Meritage Port holds 44,872 shares. Oakbrook Invs Ltd Liability Company has 182,824 shares. The United Kingdom-based Rathbone Brothers Public Limited Com has invested 0.43% in Amgen Inc. (NASDAQ:AMGN). Prns Oh Adv accumulated 0.48% or 3,780 shares. 261,705 were reported by Agf Invests. The Japan-based Nomura Asset Mgmt Ltd has invested 1.08% in Amgen Inc. (NASDAQ:AMGN). Barclays Public Limited Com reported 2.30 million shares stake. Gofen & Glossberg Ltd Liability Corporation Il holds 20,088 shares or 0.13% of its portfolio. Forte Cap Ltd Llc Adv invested in 1.35% or 18,971 shares.

Among 26 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 15 Hold. Therefore 42% are positive. Amgen Inc. had 95 analyst reports since August 3, 2015 according to SRatingsIntel. The stock has “Overweight” rating by Atlantic Securities on Friday, December 18. The company was maintained on Wednesday, July 26 by UBS. The company was maintained on Monday, February 12 by Mizuho. The firm has “Market Perform” rating by Wells Fargo given on Friday, December 4. The stock has “Neutral” rating by JP Morgan on Wednesday, January 24. Argus Research maintained the stock with “Buy” rating in Monday, February 8 report. Oppenheimer maintained it with “Buy” rating and $18900 target in Monday, June 26 report. The rating was upgraded by Piper Jaffray to “Overweight” on Thursday, November 5. The stock of Amgen Inc. (NASDAQ:AMGN) earned “Outperform” rating by Oppenheimer on Tuesday, December 13. On Friday, July 31 the stock rating was maintained by Deutsche Bank with “Buy”.

Amgen Inc. (NASDAQ:AMGN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts